Volume 23, Issue 3

Search all Heart Failure Reviews articles

May 2018

Antidiabetic Medications in Heart Failure

Issue Editor:

David E. Lanfear

15 articles in this issue

The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
Anne Pernille Ofstad
Dan Atar
Odd Erik Johansen
ReviewPaper Open access 08 March 2018 Pages: 303 - 323
Clinical impact of oral antidiabetic medications in heart failure patients
Alberto Palazzuoli
Elena Ceccarelli
Ranuccio Nuti
ReviewPaper 23 January 2018 Pages: 325 - 335
The impact of oral anti-diabetic medications on heart failure: lessons learned from preclinical studies
Vaia Lambadiari
George Dimitriadis
Nikolaos P. E. Kadoglou
ReviewPaper 10 March 2018 Pages: 337 - 346
Still sour about lactic acidosis years later: role of metformin in heart failure
William Kuan
Craig J. Beavers
Maya E. Guglin
ReviewPaper 04 September 2017 Pages: 347 - 353
DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics
Chayakrit Krittanawong
Andrew Xanthopoulos
Marrick Kukin
ReviewPaper 06 October 2017 Pages: 355 - 361
Molecular and clinical roles of incretin-based drugs in patients with heart failure
Bassant Orabi
Rasha Kaddoura
Abdulaziz Alkhulaifi
ReviewPaper 23 April 2018 Pages: 363 - 376
Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors
Vasiliki Bistola
Vaia Lambadiari
John Parissis
ReviewPaper 31 January 2018 Pages: 377 - 388
Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance
Evangelos Oikonomou
Konstantinos Mourouzis
Dimitris Tousoulis
ReviewPaper 17 February 2018 Pages: 389 - 408
SGLT2 inhibition and heart failure—current concepts
Joaquim Silva Custodio Jr
Andre Rodrigues Duraes
Leonardo Roever
ReviewPaper 28 April 2018 Pages: 409 - 418
Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects
Abdullah Kaplan
Emna Abidi
Fouad A. Zouein
ReviewPaper 11 January 2018 Pages: 419 - 437
Potential impact of SGLT2 inhibitors on left ventricular diastolic function in patients with diabetes mellitus
Hidekazu Tanaka
Ken-ichi Hirata
ReviewPaper 12 January 2018 Pages: 439 - 444
The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus
Rabea Asleh
Mohammad Sheikh-Ahmad
Sudhir S. Kushwaha
ReviewPaper 22 December 2017 Pages: 445 - 459
Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure
Yvonne May Fen Chia
Tiew-Hwa Katherine Teng
Carolyn S. P. Lam
ReviewPaper 31 January 2018 Pages: 461 - 468
Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment
Paola Terlizzese
Fabrizio Losurdo
Nadia Aspromonte
ReviewPaper 10 January 2018 Pages: 469 - 479
Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure
Yana Anfinogenova
Elena V. Grakova
Sergey V. Popov
ReviewPaper 29 August 2017 Pages: 481 - 497

Volume 23, Issue 3

Search

Navigation